SYNOPSIS Aggregation induced by adenosine diphosphate is inhibited by adenosine as well as by adenosine mono-and triphosphate. Thrombin-induced aggregation is also inhibited by adenosine and the monophosphate, but the triphosphate at a similar concentration is not inhibitory. Aggregation induced by tri-ethyl tin is accelerated by a critical concentration of triphosphate and delayed by a higher concentration. The tri-ethyl tin effect is inhibited by 5-hydroxytryptamine and by tryptamine. Platelets from patients treated with reserpine respond normally to these last two substances. Incubated platelets lose first their ability to respond normally to tri-ethyl tin, then to thrombin, and lastly to adenosine diphosphate. These results are briefly discussed.
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A new and sensitive method of studying platelet aggregation, that is, the adhesion of one platelet to another, was recently reported (O'Brien, 1962) and it was suggested it might help towards a more detailed understanding of the problems of aggregation. Some further observations are reported here. Of particular interest is the finding that 5-hydroxytryptamine is shown to have an effect on platelet behaviour. Some possible implications of these findings will be discussed in another paper.
METHOD
As previously described, 2 ml. of pooled human citrated platelet-rich plasma containing about 400,000 platelets and 400 white cells per c.mm. was placed in a magnetically stirred cuvette at 37°C. in a colorimeter. The optical density was recorded at five-second intervals. If aggregation occurred the optical density decreased. If the clumped platelets came apart the optical density increased. Additions to give the final concentrations reported were added in 0-1 ml. of barbitone-buffered saline.
RESULTS

ADENOSINE INHIBITION OF ADENOSINE DIPHOSPHATE-
INDUCED AGGREGATION Adenosine diphosphate, final concentration 5M x 10-7, added to stirred platelet-rich plasma caused moderate aggregation and then disaggregation. The prior addition of Received for publication 8 March 1963. adenosine 5M x 10-6 prevented aggregation. If 10 times as much diphosphate was used the amount of adenosine needed to inhibit it also had to be increased. Adenosine mono-and triphosphate were inhibitory in the same manner and at the same strengths. On some occasions adenosine seemed to be fractionally more inhibitory than the phosphates. of 5-hydroxytryptamine creatinine sulpahte or tryptamine hydrochloride, 5M x 10-4, 10 minutes before tri-ethyl tin sometimes completely inhibited aggregation. 5-Hydroxytryptamine, 1 25M x 10-', usually prevented tin-induced aggregation. On occasions when 5-hydroxytryptamine was ineffective at the normal pH 7 3, these concentrations were inhibitory if the pH of the platelet-rich plasma was adjusted to 8-0 by the addition of sufficient sodium hydroxide. This change of pH had no effect on aggregation induced by tri-ethyl tin alone. If the concentration of tri-ethyl tin was increased or decreased within the narrow effective range M x 10-4 to 2M x 10-6 the strength of 5-hydroxytryptamine needed to inhibit the reaction also had to be increased (1 25M x 10-') or decreased (5 x M-4) in parallel. Creatinine sulphate at the same concentration was not inhibitory and neither tryptamine nor 5-hydroxytryptamine at these concentrations inhibited thrombin and adenosine diphosphate-induced aggregation.
EFFECT Grette (1962) , have shown that thrombin causes intrinsic adenosine triphosphate in platelets to change in minutes to adenosine diphosphate, and thus presumably aggregation induced by thrombin is due to the formation and liberation of intrinsic adenosine diphosphate. The effect of adding adenosine triphosphate is therefore of theoretical importance. At a suitable concentration it might constitute an increase in the available substrate and thus speed up or increase the response to thrombin. No such effect was found but the result of adding triphosphate was nevertheless anomalous. Monophosphate, 5M x 10-6, or adenosine, 5M x 10-6, were inhibitory. Triphosphate at this strength is as inhibitory as adenosine or the monophosphate when aggregation is induced by diphosphate, but permits full thrombin-induced aggregation; presumably it had been converted into diphosphate. The high concentration of triphosphate (5M x 10-3) needed to inhibit thrombin-induced aggregation is presumably effective because the great excess successfully competes with the diphosphate formed.
The observation that a critical concentration of adenosine triphosphate accelerates the aggregation caused by tri-ethyl tin is compatible with the suggestion that tri-ethyl tin stimulates an adenosine triphosphatase in platelets (O'Brien, 1963) , particularly since tri-ethyl tin is known to stimulate mitochondrial adenosine triphosphatase (Aldridge, 1958). As in the case of thrombin-induced aggregation excess triphosphate might be expected to compete with the diphosphate formed and delay (or inhibit) aggregation, as was in fact observed.
Small quantities of adenosine diphosphate added with or immediately before tri-ethyl tin virtually eliminates the long and curious delay before triethyl tin normally causes aggregation. At present no explanation is offered.
It is of great interest that 5-hydroxytryptamine and tryptamine inhibit the effect of tri-ethyl tin, and 5-hydroxytryptamine is more effective in an alkaline medium. 5-Hydroxytryptamine is extensively distributed in the body and has many well-studied pharmacological effects but no record has been found (apart possibly from the following reports) of it being involved in a system that must involve one or at most a few enzymes. Born, Ingram, and Stacey (1958) found that the amount of 5-hydroxytryptamine normally taken up by platelets depended on the concentration of adenosine triphosphate in the platelets. Sano, Kakimoto, and Taniguchi (1958) found that added adenosine triphosphate increased uptake of 5-hydroxytryptamine. Accordingly, it seems that uptake of 5-hydroxytryptamine may in some circumstances depend on a metabolic pathway involving adenosine triphosphate. Thus, if it is accepted that tri-ethyl tin stimulates an ATPase, the metabolism of each compound may affect the metabolism of the other. In reserpinized platelets the adenosine triphosphate level is normal but these platelets cannot take up 5-hydroxytryptamine. The present observation that reserpinized platelets behave normally with 5-hydroxytryptamine and tri-ethyl tin is therefore anomalous.
Platelets increasingly damaged by ageing lose their ability to respond to diphosphate after they have lost their ability to respond to thrombin and tri-ethyl tin. This is a necessary finding if it is true that triethyl tin and thrombin cause aggregation by liberating or making available intrinsic adenosine diphosphate. 
